Planning for breakthroughs
Project Cure CRC is a 360-degree approach to curing colorectal cancer, led by a $100 million philanthropic investment and strategic efforts to influence public funding.
Funding urgent science
The cornerstone effort of Project Cure CRC is a $100 million fund for research breakthroughs, the largest philanthropic investment in CRC research ever. A rolling request for proposals seeks to advance science early-career and senior investigators, teams, startups, and others, with a special interest in collaborative science.
Influencing public funds
In addition to direct funding, the Alliance seeks to facilitate a supercharged path toward a cure by influencing public funds. Policy experts are targeting $380 million in funding at the National Cancer Institute (NCI) and $20 million in the Congressionally Directed Medical Research Programs (CDMRP).
"We will not stop"
Alliance leaders share the urgency behind Project Cure CRC.
Innovating clinical trial infrastructure
Treatment options for metastatic CRC lag behind those of other advanced cancers. The result is a dire 13% mCRC survival rate. The Alliance endeavours to create an innovative clinical trial infrastructure to bring promising treatments to patients faster.
Energizing data
The Alliance will accelerate bench-to-bedside research with a patient-centric CRC support portal that benefits patients, physicians, and researchers. Data will identify unmet needs, facilitate second opinions, improve the accessibility of clinical trials, emphasize longitudinal surveillance, and more.
